Cargando…
Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use
Transplantation is limited by the need for life-long pharmacological immunosuppression, which carries significant morbidity and mortality. Regulatory T cell (Treg) therapy holds significant promise as a strategy to facilitate immunosuppression minimization. Polyclonal Treg therapy has been assessed...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482792/ https://www.ncbi.nlm.nih.gov/pubmed/32977154 http://dx.doi.org/10.1016/j.cellimm.2020.104214 |